We are committed to finding a cure for WM.
2019 WMFC Educational Forum Presentation – Dr. Ansell
Dr. Stephen Ansell, Professor of Medicine, Mayo Clinic
Presenting: Immunotherapy – Getting the immune system to target WM cells
2019 WMFC Educational Forum Presentation – Dr. Treon
Dr. Steven Treon – Bing Center for Waldenstroms Macroglobulinemia, Dana Farber Cancer Institute, Harvard Medical School
Presenting: Waldenstroms Macroglobulinemia: Genomic Based Treatment Advances
2019 WMFC Educational Forum Presentation – Dr. Matous
Dr. Jeffery Matous, Colorado Blood Cancer Institute
Presenting: Waldenstroms Macroglobulinemia: Basic Training for Patients
Video: First-Line Treatment for Waldenstroms Macroglobulinemia
Experts remark on goals of therapy and considerations for first-line therapy in patients with Waldenström macroglobulinemia.
Source: OncLive
Video: Approaching Newly Diagnosed Waldenstrom Macroglobulinemia
Insights From: Meletios A. Dimopoulos, MD, the National and Kapodistrian University of Athens School of Medicine; Steven P. Treon, MD, PhD, Dana-Farber Cancer Institute
Published: Friday, Mar 29, 2019
SOURCE: ONCLIVE – https://www.onclive.com/insights/treatment-updates-waldenstrom-macroglobulinemia/approaching-newly-diagnosed-waldenstrom-macroglobulinemia
News: Health Canada has approved the use of Ibutrinib/rituximab combination
In a press release issued March 8th it was announced that Health Canada has approved the use of Ibutrinib in combination with rituximab for both first and later lines of treatment for patients of Waldenstroms Macroglobulinemia.
The release has been… Continue reading
Video: Waldenstrom Macroglobulinemia: When to Initiate Therapy
Source: www.curetoday.com
For the transcript please CLICK HERE
Video: A Historic Perspective on Frontline WM Management
Source: www.curetoday.com
For the transcript please CLICK HERE
Video: Selecting Therapy Through Multiple Lines in WM
Video: Waldenstrom Macroglobulinemia: Diagnostic Criteria
Insights From: Meletios A. Dimopoulos, MD, the National and Kapodistrian University of Athens School of Medicine; Steven P. Treon, MD, PhD, Dana-Farber Cancer Institute
Published: Friday, Mar 22, 2019
